TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 41, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-05-17
DOI
10.1186/s13046-022-02377-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bladder tumor subtype commitment occurs in carcinoma in-situ driven by key signaling pathways including ECM remodeling
- (2021) Adrian Wullweber et al. CANCER RESEARCH
- TSPAN7 Exerts Anti-Tumor Effects in Bladder Cancer Through the PTEN/PI3K/AKT Pathway
- (2021) Xi Yu et al. Frontiers in Oncology
- TEAD4 as a Prognostic Marker Promotes Cell Migration and Invasion of Urinary Bladder Cancer via EMT
- (2021) Zhengnan Huang et al. OncoTargets and Therapy
- Nuclear TEAD4 with SIX1 Overexpression is an Independent Prognostic Marker in the Stage I–III Colorectal Cancer
- (2021) Tong Yu et al. Cancer Management and Research
- The oncogenic role of the cerebral endothelial cell adhesion molecule (CERCAM) in bladder cancer cells in vitro and in vivo
- (2021) Yali Zuo et al. Cancer Medicine
- lncRNA ADAMTS9-AS1 promotes bladder cancer cell invasion, migration, and inhibits apoptosis and autophagy through PI3K/AKT/mTOR signaling pathway
- (2021) Guoqing Yang et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- ID2 Inhibits Bladder Cancer Progression and Metastasis via PI3K/AKT Signaling Pathway
- (2021) Weipu Mao et al. Frontiers in Cell and Developmental Biology
- PHLDA2 regulates EMT and autophagy in colorectal cancer via the PI3K/AKT signaling pathway
- (2020) Zhan Ma et al. Aging-US
- ZNF139/circZNF139 promotes cell proliferation, migration and invasion via activation of PI3K/AKT pathway in bladder cancer
- (2020) Jie Yao et al. Aging-US
- Guidelines and definitions for research on epithelial–mesenchymal transition
- (2020) Jing Yang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Overexpression of GAS6 Promotes Cell Proliferation and Invasion in Bladder Cancer by Activation of the PI3K/AKT Pathway
- (2020) Shiyu Mao et al. OncoTargets and Therapy
- Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival
- (2020) Yu-Li Su et al. Cells
- Bladder Cancer
- (2020) Andrew T. Lenis et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis
- (2019) Ran Wei et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Context-dependent EMT programs in cancer metastasis
- (2019) Nicole M. Aiello et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Regulation of TEAD Transcription Factors in Cancer Biology
- (2019) Hyunbin D. Huh et al. Cells
- Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells
- (2019) Yanju Wu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- An EMT‐related gene signature for the prognosis of human bladder cancer
- (2019) Rui Cao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis
- (2019) Joep J. de Jong et al. Genome Medicine
- TEAD4 exerts pro-metastatic effects and is negatively regulated by miR6839-3p in lung adenocarcinoma progression
- (2018) Qun Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- TEAD4 overexpression promotes epithelial-mesenchymal transition and associates with aggressiveness and adverse prognosis in head neck squamous cell carcinoma
- (2018) Wei Zhang et al. Cancer Cell International
- Mesenchymal–epithelial transition in development and reprogramming
- (2018) Duanqing Pei et al. NATURE CELL BIOLOGY
- Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
- (2017) J. Alfred Witjes et al. EUROPEAN UROLOGY
- EMT, cell plasticity and metastasis
- (2016) Christine L. Chaffer et al. CANCER AND METASTASIS REVIEWS
- The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder Tumours
- (2016) Peter A. Humphrey et al. EUROPEAN UROLOGY
- Bladder cancer
- (2016) Ashish M Kamat et al. LANCET
- Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling
- (2016) P-F Zhang et al. Cell Death & Disease
- Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial–mesenchymal transition and metastasis in a YAP-independent manner
- (2015) Y Liu et al. ONCOGENE
- A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition
- (2015) Wenting Xu et al. Cell Adhesion & Migration
- Role of aberrant PI3K pathway activation in gallbladder tumorigenesis
- (2015) Andrea Lunardi et al. Oncotarget
- Emerging roles of TEAD transcription factors and its coactivators in cancers
- (2013) Ajaybabu V. Pobbati et al. CANCER BIOLOGY & THERAPY
- An Integrin-Linked Machinery of Cytoskeletal Regulation that Enables Experimental Tumor Initiation and Metastatic Colonization
- (2013) Tsukasa Shibue et al. CANCER CELL
- Cadherin Switching and Bladder Cancer
- (2010) Richard T. Bryan et al. JOURNAL OF UROLOGY
- Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer
- (2009) David J. McConkey et al. CANCER AND METASTASIS REVIEWS
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Biomarkers for epithelial-mesenchymal transitions
- (2009) Michael Zeisberg et al. JOURNAL OF CLINICAL INVESTIGATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started